New tablet vs standard medicine for enlarged prostate
Part of Kidney & urinary clinical trials.
This trial tests a new, once-daily tablet (H077) compared to the standard medicine silodosin for treating symptoms of an enlarged prostate. It aims to see if the new medicine works as well and is safe.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a man between 50 and 75 years old.
- You have been diagnosed with an enlarged prostate (benign prostatic hyperplasia).
- You have moderate to severe urinary problems, like a weak stream or frequent urination.
- Your prostate is at least 20 mL (size of a golf ball or larger) as seen on an ultrasound.
- You have not had prostate surgery or certain other procedures for your prostate.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares two medications, silodosin and tamsulosin, to see which one works better for men with frequent or difficult urination caused by an enlarged prostate. All participants will try both medicines at different times to find the best option.
This study tests whether taking tadalafil (at 2.5 mg or 5 mg) along with tamsulosin is better for treating urinary symptoms caused by an enlarged prostate than taking tamsulosin alone. It aims to find the best dose combination to improve your quality of life.
This study is for men with moderate to severe BPH symptoms who haven't responded well to one medicine alone. It tests a combination of two drugs (solifenacin and tamsulosin) to see if they improve symptom control and quality of life.
This trial is for people with enlarged prostate (benign prostatic hyperplasia) who are already on medication or have had surgery. It aims to understand how well treatments work and how they affect quality of life.
This study compares two medications for an enlarged prostate to see how they affect the size of the pupil and the thickness of a layer in the back of the eye. It may help you understand potential eye-related side effects of these treatments.
This study compares two prostate medications (tamsulosin and silodosin) to see how they might affect the iris — the colored part of your eye. It may help doctors choose the best option for men who also have concerns about their eyes.
Hear when a new Benign Prostatic Hyperplasia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.